Retinal Screening in Primary Care
Multiple manufacturers
Several authorized autonomous retinal screening systems are indicated for use in primary care rather than ophthalmology, which makes primary care the highest-volume deployment setting for autonomous diagnostic AI in the United States.
At A Glance
- Manufacturer
- Multiple manufacturers
- Medical specialty
- Primary Care and Laboratory
- Clearance route
- Varies
- Year authorized
- Ongoing
- Modality
- Retinal photography
- Role in workflow
- Autonomous diagnostic
This entry is a pattern rather than a product. The autonomous devices listed under ophthalmology on this site are, in deployment terms, primary care devices. That is the whole point of authorizing autonomy: the value is created where the specialist is not.
See the ophthalmology records for the individual authorized systems.
Where It Is Used
- Diabetic retinopathy screening during a routine diabetes visit
- Closing screening gaps in patients who never reach an eye clinic
- Pharmacy and community health screening programs
Limitations Worth Knowing
Deployment outside a specialist setting places the operational burden ... image quality, referral follow-through, and result communication ... on staff who do not do this work routinely. Screening only produces benefit if positives actually reach an ophthalmologist, and referral leakage is the recurring failure in real programs.
Regulatory status, indications, and labeling change over time. Confirm current status on the FDA's AI/ML-Enabled Medical Devices list and in the manufacturer's current instructions for use before relying on anything stated here.